CompaniesFlare Therapeutics
Flare Therapeutics logo

Flare Therapeutics

active
Cambridge, MA, United States
Founded 2021
Website
About

Therapeutics Targeting Transcription Factors

Areas of Focus

Categories

Small Molecule PharmaceuticalBoston & New England
Team (15)
Aaron Davis
Flare Therapeutics
team_member
Abbie Celniker, Ph.D.
Flare Therapeutics
team_member
Anna Protopapas
Flare Therapeutics
team_member
Craig Gordon
Flare Therapeutics
team_member
Douglas Manion, M.D., FRCP (C)
Flare Therapeutics
team_member
Fraydoon Rastinejad, Ph.D.
Flare Therapeutics
team_member
View all 15 team members →
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

75

By Phase

PHASE1: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
Today
NCT05929235
Hover over trial bars to see details

Recent Trials

NCT05929235Lead Sponsor
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma
PHASE1Recruiting
75 participants
Started: Aug 24, 2023 · Completed: Jan 30, 2027
Locations (1)
Headquarters
Cambridge, MA, United States
Map

Loading map...